Corient Private Wealth LLC Has $2.28 Billion Stock Position in The ...
π Corient Private Wealth LLC raised its GS holdings by 1,657.7% in Q4, adding 2.45 million shares to a total position of 2.6 million shares.
π° The new Corient stake is valued at $2.28 billion and represents 1.2% of the firm's total investment portfolio.
π Zacks Research downgraded GS from 'strong-buy' to 'hold,' while BNP Paribas Exane lowered its price target to $940.
π Dbs Bank raised its price objective for GS shares from $890 to $1,050 in a recent report.
π΅ Goldman Sachs declared a quarterly dividend of $4.50 per share with an ex-dividend date of June 1st.
π The stock currently trades at a P/E ratio of 20.09 and has a market capitalization of $324.35 billion.
π¦ Institutional investors hold 71.21% of the company's outstanding stock, indicating strong institutional interest.
π CFO Denis Coleman sold 6,857 shares worth $6.68 million, reducing his personal ownership by 18.08%.
π Insider Kathryn Ruemmler sold 14,292 shares worth $13.42 million, cutting her stake by nearly half.
π Total insider selling over the last three months reached 33,681 shares valued at approximately $31.74 million.
- Corient Private Wealth LLC executed a massive 1,657.7% increase in its GS position, signaling strong institutional confidence in the stock.
- Multiple other major investors including Robeco Institutional Asset Management B.V., Rathbones Group PLC, and Global Retirement Partners LLC increased their stakes during the recent quarters.
- Dbs Bank raised its price target to $1,050, suggesting a bullish outlook on the company's future performance.
- The company maintains a healthy dividend yield of 1.6% with an annualized payout of $18.00 per share.
- Institutional ownership remains robust at 71.21%, providing stability to the stock price.
- Zacks Research downgraded GS from 'strong-buy' to 'hold,' reflecting concerns about recent performance or valuation.
- BNP Paribas Exane reduced its price target from $970 to $940 and assigned a 'neutral' rating.
- Wells Fargo & Company lowered its price objective from $1,050 to $1,000 despite maintaining an 'overweight' rating.
- CFO Denis Coleman sold 6,857 shares worth $6.68 million, indicating a reduction in personal exposure.
- Insider Kathryn Ruemmler sold 14,292 shares worth $13.42 million, representing a significant 47.72% decrease in her holdings.
- The stock has experienced volatility with a 12-month low of $630.01 compared to a high of $1,125.00.
- Analyst consensus is currently 'Hold' with an average target price of $941.82, which is below the recent trading price of $1,099.46.